The role of presepsin, c-reactive protein and procalcitonin as a marker of therapy response and prognosis for late onset neonatal sepsis in preterm neonates
Introduction: C-reactive protein (CRP) and procalcitonin (PCT) are the most widely used diagnostic and monitoring markers of neonatal sepsis.
There is currently a new sepsis marker, Soluble CD14 subtype (sCD14-ST) presepsin. This study aims to determine the benefits of serial serum presepsin examination, CRP and PCT as well as the correlation between presepsin levels with CRP and PCT levels as a marker of therapy response and prognosis of late-onset neonatal sepsis (LONS) in preterm neonates.
There is currently a new sepsis marker, Soluble CD14 subtype (sCD14-ST) presepsin. This study aims to determine the benefits of serial serum presepsin examination, CRP and PCT as well as the correlation between presepsin levels with CRP and PCT levels as a marker of therapy response and prognosis of late-onset neonatal sepsis (LONS) in preterm neonates.